Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.
about
Update on treatment of light chain amyloidosisRepurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trialAn overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chainAmyloidosis and POEMS syndrome.Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trialAmyloidosis: pathogenesis and new therapeutic options.High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement.Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65.A prospective study of nutritional status in immunoglobulin light chain amyloidosis.Autologous stem cell transplantation and IgM amyloidosis.Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reactionPerspectives in treatment of AL amyloidosis.Incidence, diagnosis and prognosis of cardiac amyloidosis.The burden of amyloid light chain amyloidosis on health-related quality of life.Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis.Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis.The patient's perspective on the symptom and everyday life impact of AL amyloidosis.Disease burden of systemic light-chain amyloidosis: a systematic literature review.A clinical staging score to measure the severity of dialysis-related amyloidosis.Hematology patient reported symptom screen to assess quality of life for AL amyloidosis.High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.Vertebra collapse due to primary amyloidosis causing neurological compromise.Autologous stem cell transplant for Al amyloidosis.Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study.Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis.Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time.Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples.Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients.Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis.Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis.AbstractsA good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 year
P2860
Q26829735-353E86AA-47BD-4B98-ACAA-99F9E57A1409Q28304712-1813231E-E3E8-40A1-AEF0-96FD77471633Q33304297-DD17EDEE-BC13-48F3-80F2-75BA1B49D472Q33840466-CB27517A-A976-438F-820C-23E92706BA53Q33867198-CF1603E4-E9C1-4586-9B3D-FB941A405315Q34482518-621BB129-B559-485E-9D6B-14252DBD897CQ35081363-34732C0C-AD11-40B7-ADE6-865F752383A7Q35111771-E8BF5BE8-3951-47D9-91D9-DFAEB85A56ACQ35750326-AE7521DF-2348-4405-A7F4-3B6183325367Q35848844-9B74E70D-5763-4B1A-A000-CB7305D9FE20Q36498408-6AC978B9-C2BE-4463-8523-5736F9B25046Q36535491-694B3D68-C476-4621-891C-EC2BB1B82957Q36901282-581DE60A-8262-4A1A-8C01-9422412A70A0Q37045885-4FCD91AC-6FDE-444B-9123-ACBBD227BF9AQ37399628-EA3EFD59-328A-4E5B-A559-7F48E681DE4BQ37593524-7232FC57-BD45-4D5E-B134-70C544030BB4Q37904673-07845119-9499-41CA-90BE-C3228DBD73CFQ37995198-C744A543-E17E-4286-A755-6E01D32DC360Q37999957-10233A4D-7D55-4D9F-8DEC-18989135D9E4Q38639919-44110ED6-38D5-4C91-820B-5375147CDBC2Q38917828-75BBE00B-5A6A-41B7-98EC-03AC5B04D735Q39658631-2FC45BFD-C254-4363-9798-05BF81D26E1CQ40343246-6BE0B2A2-00FB-435D-B60F-EBF9F258A0A4Q41723913-C12004CF-697B-4D23-B8A1-4D0AC99C79D8Q41822878-3AD692BD-7BB1-4435-AB6A-F46A6D39FA0CQ42179759-6C34D6C6-8927-4E67-AECC-178168E22730Q42907761-819497F0-C0C7-45FD-AA09-D642656851B6Q44248482-B7C58787-291A-40DF-A13C-34BBE3743199Q46980729-96D28039-C542-4298-9B86-9C73DF53DE9FQ47096627-C2A99BC2-27C9-4BD0-A34A-2EFD30CEF3F7Q47160869-573D7EEA-CEB5-410A-B377-F5C2DAFA2FC5Q47383265-A1F9F2DB-45C2-4C7E-9F39-220B4297317AQ48615482-03FA7978-4E65-4F83-9CB5-0759F9B4071FQ51389775-5DCEEFE8-A672-4A68-A489-CA506F77BCB4Q53504425-7ACA6F3A-A680-41BA-9242-A3094496C891Q57259399-DD2EE09E-73DA-4AAE-9712-40D948D1ADB3Q58275488-D6E1AAD4-99D1-4A43-B078-FF80A5B5FC1E
P2860
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Improvement in quality of life ...... ous stem cell transplantation.
@en
Improvement in quality of life ...... ous stem cell transplantation.
@nl
type
label
Improvement in quality of life ...... ous stem cell transplantation.
@en
Improvement in quality of life ...... ous stem cell transplantation.
@nl
prefLabel
Improvement in quality of life ...... ous stem cell transplantation.
@en
Improvement in quality of life ...... ous stem cell transplantation.
@nl
P2093
P50
P1433
P1476
Improvement in quality of life ...... ous stem cell transplantation.
@en
P2093
Daniel G Wright
David C Seldin
Jennifer J Anderson
Karim Malek
Kathleen T Finn
Laura M Dember
Martha Skinner
Rodney H Falk
P304
P356
10.1182/BLOOD-2004-01-0089
P407
P577
2004-05-20T00:00:00Z